'Vision 2020 Netherlands': A World Health Organization project against avoidable visual impairment in the Netherlands;Vermijdbare slechtziendheid in Nederland: Het project 'Vision 2020 Netherlands' van de Wereldgezondheidsorganisatie

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 11, 2005, Pages 577-582

  Limburg, H ^a   Den Boon, J M ^b   Hogeweg, M ^c   Gevers, R J T ^d   Ten Hove, G Th ^e   Keunen, J E E ^f  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Medical Centre Alkmaar   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Optometristen Vereniging Nederland   (Netherlands)

^e Stichting Dark and Light Blind Care   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES MELLITUS; HIGH RISK POPULATION; HUMAN; INTELLECTUAL IMPAIRMENT; MASS SCREENING; NETHERLANDS; REVIEW; VISUAL IMPAIRMENT; WORLD HEALTH ORGANIZATION;

HEALTH PROMOTION; HUMANS; MASS SCREENING; NETHERLANDS; RISK FACTORS; VISION DISORDERS; WORLD HEALTH ORGANIZATION;

EID: 15244339994     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull WHO 2004;82:844-51.
2. Global initiative for the elimination of avoidable blindness. WHO/PBL/97.61 Rev. 2. Genève: WHO; 2000.
3. Consultation on development of standards for characterization of visual loss and visual functioning. WHO/PBL/03.91. Genève: WHO; 2003.
4. Frick KD, Foster A. The magnitude and cost of global blindness: an increasing problem that can be alleviated. Am J Ophthalmol 2003;135:471-6.
5. Klaver CCW, Wolfs RCW, Vingerling JR, Hofman A, Jong PVTM de. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 1998;116:653-8.
6. Congdon N, O'Colmain B, Klaver CCW, Klein R, Munoz B, Friedman DS, et al. Causes and prevalence of visual impairment among adults in the United States. Eye Diseases Prevalence Research Group. Arch Ophthalmol 2004;122:477-85.
7. Melief WBAM, Gorter KA. Slechtzienden en blinden in Nederland. Deelrapport I. Aantallen en kenmerken. Verwey-Jonker Instituut, Utrecht. Tilburg: Regeer & Reijnen; 1998.
8. Elimination of avoidable visual disability due to refractive errors. WHO/PBL/00.79. Genève: WHO; 2000.
9. Splunder J van, Stilma JS, Bernsen RM, Evenhuis HM. Prevalence of ocular diagnoses found on screening 1539 adults with intellectual disabilities. Ophthalmology 2004;111:1457-63.
10. Winter LJM de, Hoyng CB, Froeling PGAM, Meulendijks CFM, Wilt GJ van der. Prevalence of remediable disability due to low vision among institutionalized elderly people. Gerontology 2004;50:96-101.
11. Evans JR, Fletcher AE, Wormald RPL, Ng ES, Stirling S, Smeeth L, et al. Prevalence of visual impairment in people aged 75 years and older in Britain: results from the MRC trial of assessment and management of older people in the community. Br J Ophthalmol 2002;86:795-800.
12. Kempen JH, O'Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, et al. The prevalence of diabetic retinopathy among adults in the United States. Eye Diseases Prevalence Research Group. Arch Ophthalmol 2004;122:552-63.
13. Crijns H, Casparie AF, Hendrikse F. Toekomstige behoefte aan oogzorg voor patiënten met diabetes mellitus, kosten en effectiviteit. Ned Tijdschr Geneeskd 1995;139:1336-41.
14. Hendrikse F, Webers CAB, Heij EC la. Hoe vaak komen gezichtsstoornissen voor? In: Volksgezondheid Toekomst Verkenning, Nationaal Kompas Volksgezondheid. Bilthoven: RIVM; 2003.